Quiz for DJR-153
Quiz Summary
0 of 8 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 8 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 8
1. Question
The goal of this study was to evaluate the ______ of therapeutic-dose anticoagulation during CDT for acute PE, as it manifests in hemorrhagic complications.
CorrectIncorrect -
Question 2 of 8
2. Question
Included were patients who presented with acute submassive or massive PE within ____ days of symptom onset and underwent pulmonary artery CDT (unilateral or bilateral) with recombinant tissue plasminogen activator (TPA).
CorrectIncorrect -
Question 3 of 8
3. Question
What clinical presentations were included in the author’s review?
CorrectIncorrect -
Question 4 of 8
4. Question
According to the Global Use of Strategies to Open Occluded Arteries (GUSTO) scale, which one of the following had the most hemorrhagic complications by pulmonary embolism severity, including both Submassive and Massive PE?
CorrectIncorrect -
Question 5 of 8
5. Question
Which of the following were observed most commonly in the study population?
CorrectIncorrect -
Question 6 of 8
6. Question
What was the biggest complication rate during this study?
CorrectIncorrect -
Question 7 of 8
7. Question
No significant difference was found between the LMWH and heparin groups in these parameters
CorrectIncorrect -
Question 8 of 8
8. Question
Which of the following were considered limitations during the current study?
CorrectIncorrect